16076-86-1 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-7-methylindole-3-carboxaldehyde is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and reactivity. Its presence in the molecular composition of target compounds can contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Bromo-7-methylindole-3-carboxaldehyde is utilized as a precursor in the synthesis of agrochemicals, potentially enhancing the effectiveness of pesticides, herbicides, and other agricultural chemicals.
Used in Organic Material Synthesis:
5-Bromo-7-methylindole-3-carboxaldehyde is employed as a key component in the creation of organic materials, where its chemical properties can be leveraged to produce materials with tailored characteristics for specific applications.
Used in Dye and Pigment Production:
As an intermediate in the production of dyes and pigments, 5-Bromo-7-methylindole-3-carboxaldehyde contributes to the development of colorants with unique hues and properties, suitable for various industries such as textiles, plastics, and printing.
Used in Fine Chemicals Industry:
In the fine chemicals industry, 5-Bromo-7-methylindole-3-carboxaldehyde is used as an intermediate for the synthesis of specialty chemicals, which often have high added value and are used in niche applications such as fragrances, flavorings, and high-performance materials.
Check Digit Verification of cas no
The CAS Registry Mumber 16076-86-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,7 and 6 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 16076-86:
(7*1)+(6*6)+(5*0)+(4*7)+(3*6)+(2*8)+(1*6)=111
111 % 10 = 1
So 16076-86-1 is a valid CAS Registry Number.
16076-86-1Relevant academic research and scientific papers
Calcitonin gene related peptide receptor antagonists
-
, (2008/06/13)
The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.
